Aptamer Group and BaseCure Therapeutics join hands for new targeted gene therapies EP News Bureau Feb 1, 2023 Optimer delivery vehicles could increase uptake of the siRNA therapy into the target cells
Aptamer, PinotBio partner for development of new therapeutic drug conjugates EP News Bureau Jun 2, 2021 Optimer-drug conjugates offer uniquely specific targeting vehicles for the delivery of therapeutic agents to selected cell…
Aptamer Group, AstraZeneca extend collaboration to explore next-gen drug delivery approaches EP News Bureau Mar 5, 2021 The companies will evaluate the potential of using Optimer-based strategies to target renal cells and explore the feasibility of…
